Overview

A Comparative Study of Intrathecal Magnesium Sulphate & Midazolam With Epidural Ropivacaine for Caesarean Patients

Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
0
Participant gender:
Female
Summary
This study compares whether addition of Magnesium or Midazolam intrathecally to epidurally administered isobaric Ropivacaine improves the quality of blockade, haemodynamics and duration of analgesia post-operatively. 25 parturients were given intrathecal Magnesium and rest of the 25 parturients were given intrathecal Midazolam combined with 0.75% Ropivacaine via epidural route.
Phase:
Phase 2/Phase 3
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Rangaraya Medical College
Treatments:
Magnesium Sulfate
Midazolam
Ropivacaine
Criteria
Inclusion Criteria:

- 50 pregnant women

- ASA-I and II parturients

- Weight 50-80 kgs

- Pre-eclampsia

Exclusion Criteria:

- Thrombocytopenia

- HELLP syndrome

- Parturients on magnesium therapy

- Foetal distress

- Parturients on benzodiazepine therapy

- Patient refusal

- Contraindications to regional anaesthesia